June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Role of Müller cell retinoic acid signaling in blood-retinal barrier maintenance
Author Affiliations & Notes
  • Lana Pollock
    Ophthalmic Research, Cleveland Clinic Cole Eye Institute, Cleveland, Ohio, United States
  • Jing Xie
    Ophthalmic Research, Cleveland Clinic Cole Eye Institute, Cleveland, Ohio, United States
  • Bela Anand-Apte
    Ophthalmic Research, Cleveland Clinic Cole Eye Institute, Cleveland, Ohio, United States
    Cell Biology, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio, United States
  • Footnotes
    Commercial Relationships   Lana Pollock None; Jing Xie None; Bela Anand-Apte None
  • Footnotes
    Support  This study was supported in part by the NIH-NEI P30 Core Grant (IP30EY025585), Unrestricted Grants from The Research to Prevent Blindness, Inc., and Cleveland Eye Bank Foundation awarded to the Cole Eye Institute, as well as NIH grants F32EY029147, R01EY026181, and T32EY024236
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 3891 – A0093. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Lana Pollock, Jing Xie, Bela Anand-Apte; Role of Müller cell retinoic acid signaling in blood-retinal barrier maintenance. Invest. Ophthalmol. Vis. Sci. 2022;63(7):3891 – A0093.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The blood-retinal barrier (BRB) mediates movement of molecules from the blood to the inner retina, protecting the neural retina from potentially harmful molecules and maintaining retinal homeostasis. We previously demonstrated that retinoic acid (RA) signaling is necessary for BRB integrity in the zebrafish model. RA signaling is known to induce expression of RA-metabolizing enzyme Cyp26a1 in a sensitive feedback mechanism. The purpose of this study was to investigate the cellular mechanisms by which RA maintains the BRB by examining the expression patterns of cyp26a1 in the retina.

Methods : To visualize the BRB in vivo, we utilized the transgenic Tg(l-fabp:DBP-EGFP) zebrafish model that expresses vitamin D binding protein (a member of the albumin gene family) tagged to GFP. This model displays the integrity of the BRB with GFP-tagged protein localized within the retinal vasculature by 3 days post-fertilization. Breakdown of the BRB is visualized as “leaking” of GFP outside the vasculature. To disrupt RA signaling, zebrafish embryos, larvae, and adults were treated with varying concentrations of DEAB and BMS493, antagonists of retinal dehydrogenase and the RA receptor, respectively. To visualize the Müller cells and endothelial cells, gfap:GFP and kdrl:GFP transgenic fish were used, respectively. RNAScope analysis was used to detect and quantify the expression of cyp26a1 in retinas of zebrafish at different developmental stages.

Results : Treatment with DEAB or BMS493 resulted in a non-functional disrupted BRB in up to 95% of embryos and adults. In the retina, cyp26a1 was primarily detected in the Müller cells starting at 3 dpf, and treatment with pharmacological RA signaling inhibitors significantly decreased Müller cell cyp26a1 expression.

Conclusions : The gene encoding RA-metabolizing enzyme Cyp26a1 is primarily expressed in the Müller cells of the retina, indicating that Müller cells may play a critical role in RA-mediated BRB maintenance.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×